THE STATUS OF ADHERENCE IN LAMIVUDIN, TENOFOVIR AND DOLUTEGRAVIR USAGE TO TREAT HIV PATIENTS. YHCĐ. 2022;63(Số tiếng Anh). doi:10.52163/yhc.v63i9.557